A Comparative Study of the Efficacy of Endovenous Laser Treatment of the Incompetent Great Saphenous Under General Anesthesia with External Air Cooling with and Without Tumescent Anesthesia

2013 ◽  
Vol 39 (2) ◽  
pp. 255-262 ◽  
Author(s):  
Esteban HernÁndez Osma ◽  
Serge R. Mordon ◽  
Mohamad Feras Marqa ◽  
Jiri Vokurka ◽  
Mario A. Trelles

2012 ◽  
Vol 28 (3) ◽  
pp. 833-844 ◽  
Author(s):  
Mohamad Feras Marqa ◽  
Serge Mordon ◽  
Esteban Hernández-Osma ◽  
Mario Trelles ◽  
Nacim Betrouni


2021 ◽  
Vol 198 ◽  
pp. 117503 ◽  
Author(s):  
Mohsen Akbarzadeh ◽  
Theodoros Kalogiannis ◽  
Joris Jaguemont ◽  
Lu Jin ◽  
Hamidreza Behi ◽  
...  




2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Vasanop Vachiramon ◽  
Pattarin Anusaksathien ◽  
Silada Kanokrungsee ◽  
Kumutnart Chanprapaph

Objective. Keratosis pilaris (KP) is a common condition which can frequently be cosmetically disturbing. Topical treatments can be used with limited efficacy. The objective of this study is to evaluate the effectiveness and safety of fractional carbon dioxide (CO2) laser for the treatment of KP.Patients and Methods. A prospective, randomized, single-blinded, intraindividual comparative study was conducted on adult patients with KP. A single session of fractional CO2laser was performed to one side of arm whereas the contralateral side served as control. Patients were scheduled for follow-up at 4 and 12 weeks after treatment. Clinical improvement was graded subjectively by blinded dermatologists. Patients rated treatment satisfaction at the end of the study.Results. Twenty patients completed the study. All patients stated that the laser treatment improved KP lesions. At 12-week follow-up, 30% of lesions on the laser-treated side had moderate to good improvement according to physicians’ global assessment (p=0.02). Keratotic papules and hyperpigmentation appeared to respond better than the erythematous component. Four patients with Fitzpatrick skin type V developed transient pigmentary alteration.Conclusions. Fractional CO2laser treatment may be offered to patients with KP. Dark-skinned patients should be treated with special caution.



2008 ◽  
Vol 34 (4) ◽  
pp. 517-524
Author(s):  
SEUNG JOON PARK ◽  
SU BIN YIM ◽  
DAE WON CHA ◽  
SUNG CHUL KIM ◽  
SEUNG HOON LEE


1993 ◽  
Vol 21 (5) ◽  
pp. 605-613
Author(s):  
LIN XIANSHU ◽  
GAO JINLING ◽  
YU GUOQIN


Thorax ◽  
1988 ◽  
Vol 43 (3) ◽  
pp. 218-218 ◽  
Author(s):  
K Moghissi ◽  
A Budd


2015 ◽  
Vol 52 (4) ◽  
pp. 226-230 ◽  
Author(s):  
Michael Kinori ◽  
Ido Didi Fabian ◽  
Abraham Spierer ◽  
Tamara Wygnanski-Jaffe ◽  
Shira L. Robbins ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document